Sue-Hwa Lin

Title: Sue-Hwa Lin: Innovator in Angiogenesis Inhibition

Introduction

Sue-Hwa Lin is a prominent inventor based in Houston, Texas. She has made significant contributions to the field of hyperproliferative diseases and angiogenesis. Her innovative work focuses on the mechanisms that inhibit angiogenesis, which is crucial for developing treatments for various diseases.

Latest Patents

Sue-Hwa Lin holds a patent for her invention titled "C-CAM as an angiogenesis inhibitor." This patent demonstrates that a C-CAM1 cytoplasmic domain is necessary and sufficient for inhibiting angiogenesis. The invention outlines methods for inhibiting hyperproliferative cell growth by administering a C-CAM1 cytoplasmic domain or an expression construct encoding it. Additionally, it describes how angiogenesis can be inhibited by administering a C-CAM1 polypeptide or an expression construct encoding this polypeptide. She has 1 patent to her name.

Career Highlights

Sue-Hwa Lin is affiliated with the University of Texas System, where she continues her research and development in the field of angiogenesis. Her work has the potential to impact the treatment of various diseases characterized by abnormal blood vessel growth.

Collaborations

Some of her notable coworkers include Weiping Luo and Christopher Logothetis. Their collaborative efforts contribute to advancing research in the field of angiogenesis and hyperproliferative diseases.

Conclusion

Sue-Hwa Lin's innovative work in angiogenesis inhibition showcases her dedication to advancing medical science. Her contributions are vital for developing new therapeutic strategies against hyperproliferative diseases.